Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
cognitive impairment associated with the accumulation of beta-amyloid protein (Aβ). Aβ …

Nanoparticles have a great potential to significantly improve the delivery of therapeutics to
the brain and may also be equipped with properties to investigate brain function. The brain …

Neurodegenerative diseases encompass a wide range of debilitating and incurable brain
disorders characterized by the progressive deterioration of the nervous system's structure …

Although a wide variety of topical microbicides provide promising in vitro and in vivo efficacy,
most of them failed to prevent sexual transmission of human immunodeficiency virus type 1 …

In recent years, a great deal of effort has been undertaken with regards to treatment of
pathologies at the level of the central nervous system (CNS). Here, the presence of the …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, memory loss, and impaired daily functioning. While there is currently no …

Alzheimer's disease (AD) is a neurodegenerative condition that exhibits a gradual decline in
cognitive function and is prevalent among a significant number of individuals globally. The …

Central nervous system (CNS) disorders have a major impact on public health and, as such,
have gained the interest of researchers to search for better strategies. Recently, the field of …

Drug-loaded, brain-targeted nanocarriers could be a promising tool in overcoming the
challenges associated with Alzheimer's disease therapy. These nanocargoes are …

Alzheimer's disease (AD) has been consistently related to the formation of senile amyloid
plaques mainly composed of amyloid β (Aβ) peptides. The toxicity of Aβ aggregates has …